Meihua International Medical TechnologiesMHUA
MHUA
About: Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
Employees: 619
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
30% more capital invested
Capital invested by funds: $87.7K [Q4 2024] → $114K (+$26.2K) [Q1 2025]
0.32% more ownership
Funds ownership: 0.98% [Q4 2024] → 1.3% (+0.32%) [Q1 2025]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
11% less funds holding
Funds holding: 9 [Q4 2024] → 8 (-1) [Q1 2025]
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Research analyst outlook
We haven’t received any recent analyst ratings for MHUA.
Financial journalist opinion
Neutral
PRNewsWire
1 month ago
Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results
YANGZHOU, China , April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024.
Neutral
PRNewsWire
8 months ago
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
YANGZHOU, China , Oct. 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement").
Neutral
PRNewsWire
8 months ago
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
YANGZHOU, China , Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd.
Neutral
PRNewsWire
9 months ago
Meihua International Medical Technologies Co., Ltd. to Present at LIVE!
YANGZHOU, China , Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that Xin "Steven" Wang, Chief Executive Officer of Meihua, will present and discuss recent corporate events at LIVE!
Neutral
PRNewsWire
10 months ago
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China , July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced that its NT-2000 surgical path analysis system successfully supported the world's second* 5G remote robot-assisted lobectomy.
Neutral
PRNewsWire
11 months ago
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors (the "Board") has approved and authorized a share repurchase program of up to $3 million of the Company's outstanding ordinary shares (the "Share Repurchase Program").
Neutral
PRNewsWire
1 year ago
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
YANGZHOU, China , June 11, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, is pleased to announce that its management team will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, and will provide an update at the Emerging Growth Conference, both events taking place on June 13, 2024.
Neutral
PRNewsWire
1 year ago
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024
Meihua International Medical Technologies Co., Ltd. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
Neutral
PRNewsWire
1 year ago
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
YANGZHOU, China , April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today reported its financial results for the fiscal year ended December 31, 2023.
Neutral
PRNewsWire
1 year ago
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
YANGZHOU, China , Jan. 2, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the closing of its previously disclosed registered direct offering with certain accredited institutional investors to purchase an initial $6 million tranche in the offering of up to $50.5 million of its 7% Original Issue Discount Senior Convertible Promissory Notes (the "Initial Notes"), and five-year ordinary share purchase warrants to purchase 1,205,255 ordinary shares of the Company (the "Initial Warrants"), exercisable at $2.9869 per ordinary share, in a concurrent private placement, for gross proceeds of approximately $5,580,000.
Charts implemented using Lightweight Charts™